COMP <GO>
WGS vs MRK // NET PROFIT MARGIN
GeneDx Holdings Corp. (Class A) (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: WGS 2
— MRK 9
▲ NET PROFIT MARGIN LEADER: MRK
LAST: $69.06 (-2.76%) • MKT CAP: $2.12B
net-margins
-4.90%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
net-margins
28.10%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (WGS VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | WGS | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.70% | 74.80% | -5.10 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -4.10% | 20.70% | -24.80 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 15.3x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 0.67% | 3.42% | -2.75 | MRK | /fcf-yield <GO> |
| Operating Margin | -3.10% | 34.30% | -37.40 | MRK | /operating-margins <GO> |
| Net Profit Margin ACTIVE | -4.90% | 28.10% | -33.00 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 40.00% | 1.30% | +38.70 | WGS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.32 | 5.19 | -1.87 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | WGS | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 50.8 | 51.7 | -0.90 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 18.4x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.12B | $361.02B | -$358.90B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | WGS REV | MRK REV | WGS GROSS % | MRK GROSS % | WGS FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $427.5M | $65.01B | 69.7% | 74.8% | $14.3M | $12.36B |
| FY 2024 | $305.4M | $64.17B | 63.6% | 76.3% | -$34.0M | $18.10B |
| FY 2023 | $202.6M | $60.12B | — | — | -$180.1M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
WGS // BETA —
MRK // BETA 0.92